$ALMU

Klamkin Jonathan sold $335K of ALMU

Klamkin Jonathan (Chief Executive Officer) sold 20,000 shares of Aeluma, Inc. (ALMU) at an average of $16.73 ($16.29–$16.85, $0.33M total) across 2 trades on 2026-08-03 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Klamkin Jonathan
Published Aug 5, 2026, 4:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 6:29 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$ALMU
Neutral
medium confidence
Mentioned
$ALMU
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ALMUNeutralLow
01

Why it matters

The newest disclosed fact is the CEO’s open-market sale size, trade dates, and the confirmation that it was executed under a pre-arranged 10b5-1 plan.

02

Market read

Traders may briefly reassess sentiment around ALMU due to insider selling, but the 10b5-1 framing usually limits fundamental interpretation.

03

What to watch

The filing does not state the CEO’s remaining compensation needs, tax strategy, or whether other insiders are selling or buying around the same period.

Relevance 3/10Novelty 3/10Timing: filed Aug 5, covering Aug 3 trades

Background

This is an SEC Form 4 insider transaction disclosure for Aeluma, Inc. (ALMU).

Company-level read

Ticker impact

$ALMUNeutralMedium confidence
Context

Aeluma CEO Klamkin Jonathan sold about $334.6K of ALMU shares in two trades under a pre-arranged 10b5-1 plan.

Expected impact

Likely limited, short-lived impact unless follow-on selling or additional disclosures emerge.

Evidence & confidence

The transaction is an open-market sale by the CEO, but it is explicitly under a pre-arranged 10b5-1 plan, which typically reduces the signal strength versus discretionary sales.

Market effects

No clear sector read-through from a single small insider sale.

None indicated.

None indicated.

Counterpoint

Because the sale is under a pre-arranged 10b5-1 plan, it may reflect liquidity planning rather than a bearish view on fundamentals.

Key entities

  • Aeluma, Inc.

    Company whose shares were sold by its CEO in an SEC Form 4 disclosure.

  • Klamkin Jonathan

    Chief Executive Officer and director who sold ALMU shares.

Related articles

$ALMUMed

The Speed of Light: 5 Stocks Powering AI’s Optical Future

MarketBeat highlights NVIDIA’s broader photonics investment and says the global photonics market is about $1.25T, growing mid-single digits through the next decade, with silicon photonics rising ~30% annually. It profiles Aeluma (NASDAQ: ALMU), citing quantum-dot lasers and a manufacturing method that grows optical-quality substrate on silicon. The article notes Aeluma is pre-revenue, seeks data-center/defense partnerships for design wins and prototype certifications, and targets production and

$ALMUMedAI 8/10

Aeluma Sees Accelerated Timeline for Quantum Commercialization

Aeluma (NASDAQ: ALMU) said the U.S. Department of Commerce announced proposed CHIPS Act incentives of more than $2 billion for nine companies to accelerate quantum computing, shifting from R&D to manufacturing. Aeluma supported one company that signed a letter of intent, with involvement contingent on a subcontract. Aeluma cited its scalable wafer platform and recent U.S. contracts for quantum materials and lasers.